Export Notification and Recordkeeping Requirements
Extension without change of a currently approved collection
No
Regular
Approved without change
07/01/2019
06/05/2019
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
07/31/2022
36 Months From Approved
06/30/2019
3,635
0
12,239
69,330
0
198,873
363,500
0
0
The information collection supports FDA regulations at 21 CFR 1.101 and pertains to the notifications and records required for human drug, biological product, device, animal drug, food, cosmetic, and tobacco product exports under sections 801 or 802 of the Federal Food, Drug, and Cosmetic Act or (21 U.S.C. 381 and 382) or section 351 of the Public Health Service Act (42 U.S.C. 262).
The information collection reflects adjustments in our estimated burden. Cumulatively these adjustments result in an overall reduction to the information collection by 8,604 annual responses and 129,543 burden hours.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.